EPISODE · Feb 13, 2019 · 18 MIN
Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline
from RARECast
It was about ten months ago that Orchard Therapeutics acquired the gene therapy portfolio of GSK, expanding its pipeline and giving it its first approved therapy. We spoke to Orchard CEO Mark Rothera about his company’s approach to gene therapy, its pipeline, and what he sees as the biggest challenges as Orchard moves towards commercializing its therapies.
Embed this episode
NOW PLAYING
Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline
0:00
18:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of RARECast?
This episode is 18 minutes long.
When was this RARECast episode published?
This episode was published on February 13, 2019.
Can I download this RARECast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!